Parkison'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Parkinson's disease receiving oral levodopa treatment who began taking an additional Parkinson's disease medication
Exclusion criteria
Exclusion criteria: Patients with a diagnosis of a disease that requires differentiation from Parkinson's disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Treatment adherence, and 2) Treatment persistence during 1-year follow-up period | — |
Countries
Japan
Contacts
Eisai Co., Ltd. Medical HQs